SUMVAX LIMITED
Company number 13403144 · Monitor this company
The confirmation statement for this company is overdue.
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£1,805,571
Balance sheet as at 2025-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-05-17
- Registered office
- 167 - 169 Great Portland Street, Fifth Floor, London, England, W1W 5PF
- Postcode
- W1W 5PF
- Capital
- 101 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-03-31
- Next due by
- 2026-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2024-05-16
- Next due by
- 2025-05-30 Overdue
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current · 3 resigned
David James SUMNER
Director
Group structure
Controlled by SUMNER GROUP HEALTH R&D LIMITED — since 2021-06-07
From persons-with-significant-control filings on the public register.
Contact details
- Website
- sumvax.com